India has proposed reciprocal zero tariffs on selected US imports — including steel, auto components, and certain pharmaceuticals — for limited quantities as part of recent trade negotiations.
The goal of this proposal is to speed the conclusion of a bilateral trade agreement before the expiration of the US administration’s 90-day tariff pause. By offering duty-free access for specified volumes, India seeks to create a focused, time-bound mechanism that could bridge outstanding differences and facilitate a quicker deal.
US negotiators have signaled concerns about India’s Quality Control Orders (QCOs), which they consider to act as non-tariff barriers that restrict market access for certain American exporters. These QCOs set product standards and mandatory testing or registration requirements that importers must meet.
In response, India has shown a willingness to re-evaluate aspects of its regulatory standards for some categories, including medical devices and certain chemicals. Officials indicate they are open to adjustments that preserve public safety while addressing foreign partners’ market access concerns, potentially easing the path to a limited reciprocal tariff arrangement.
The proposed approach emphasizes targeted, sector-specific concessions rather than broad tariff cuts. By limiting zero-tariff treatment to defined quantities, both sides aim to protect sensitive domestic industries while creating export opportunities that can be monitored and adjusted over time. For exporters, such a framework would offer predictable, short-term relief while negotiations continue on longer-term issues.
Negotiators on both sides are balancing multiple priorities: India’s interest in safeguarding public health and environmental standards through regulatory oversight, and the US concern that some regulatory measures may unintentionally impede trade. The recent discussions suggest momentum toward technical work that would reconcile regulatory objectives with trade facilitation, rather than immediate sweeping policy changes.
Any final agreement would likely include detailed rules of origin, quantity limits, and compliance procedures to ensure the concession applies only to eligible products and volumes. Monitoring and dispute-resolution mechanisms would also be important to manage any disagreements over implementation or interpretation of the tariff concessions and accompanying regulatory adjustments.
Observers note that time is a critical factor. The proposed limited zero-tariff offer is structured to fit within the current 90-day window, creating an incentive to finalize practical, enforceable terms quickly. Should negotiations succeed, the arrangement could serve as a pilot for deeper cooperation on trade and regulatory alignment in the future.
Overall, India’s proposal represents a pragmatic step intended to unblock stalled talks: offering temporary, measurable market access to select US goods while signaling readiness to engage on regulatory issues that have been a sticking point. Both sides appear to be focusing on practical, technical solutions that can be implemented within a constrained timeframe, preserving flexibility for broader negotiations later.